Company: GRCE
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001140361-25-041804
Chunk: 56

Company: Grace Therapeutics, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Item 8
Chunk 56
---

    0001444192
    
      srt:WeightedAverageMember
      grce:CommonWarrants2023Member

    2024-04-01
    2025-03-31

    0001444192
    
      us-gaap:RelatedPartyMember

    2025-09-30

    0001444192
    
      us-gaap:RelatedPartyMember

    2025-03-31

    0001444192
    
      grce:CommonWarrants2023Member

    2025-09-30

    0001444192
    
      grce:PrefundedWarrants2023Member

    2025-09-30

    0001444192
    
      grce:CommonWarrants2025Member

    2025-09-30

    0001444192
    
      grce:PrefundedWarrants2025Member

    2025-09-30

    0001444192
    
      us-gaap:MeasurementInputRiskFreeInterestRateMember

    2025-09-30

    0001444192
    
      us-gaap:MeasurementInputRiskFreeInterestRateMember

    2025-03-31

    0001444192
    
      us-gaap:MeasurementInputSharePriceMember

    2025-09-30

    0001444192
    
      us-gaap:MeasurementInputSharePriceMember

    2025-03-31

    0001444192
    
      us-gaap:MeasurementInputExpectedTermMember

    2025-09-30

    0001444192
    
      us-gaap:MeasurementInputExpectedTermMember

    2025-03-31

    0001444192
    
      us-gaap:MeasurementInputExpectedDividendRateMember

    2025-09-30

    0001444192
    
      us-gaap:MeasurementInputExpectedDividendRateMember

    2025-03-31

    0001444192
    
      us-gaap:MeasurementInputPriceVolatilityMember

    2025-09-30

    0001444192
    
      us-gaap:MeasurementInputPriceVolatilityMember

    2025-03-31

    0001444192
    
      grce:EquityIn